Research Directory

Shire Plc adds new dimension to its strategy

Read more

FDA lays out regulatory science strategy

Read more

How induced pluripotent stem cells are becoming a tool for personalised medicine

Read more

Cellzome secures a lead in drug discovery

Read more

Innate Pharma's anti-cancer platform attracts BMS investment

Read more

Update on Personalised Medicine

Read more

Is the diagnostic part of personalised medicine underpaid?

Read more

EMA gives its first opinion on human use of biomarkers

Read more

Vaccinating against the tumour vasculature

Read more

Virtual drug development at Eli Lilly

Read more